Biopsychosocial and Conventional Approach in Bladder Pain Syndrome
Primary Purpose
Interstitial Cystitis, Bladder Pain Syndrome
Status
Recruiting
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
Pain Neuroscience Education
Relaxation exercises
Cognition target exercise
Pelvic floor stretching exercises
Transcutaneous electrical nerve stimulation
Sponsored by
About this trial
This is an interventional treatment trial for Interstitial Cystitis focused on measuring chronic pain, pain neuroscience education, Bladder Pain Syndrome, Interstitial Cystitis
Eligibility Criteria
Inclusion Criteria:
- Diagnosed with Bladder Pain Syndrome/Interstitial Cystitis
- with chronic symptoms (more than 6 months)
- Bladder pain severity in the last week should be at least 3/10 according to the Visual Analogue Scale (VAS)
- Stable medication schedule
- Individuals over the age of 18 (individuals over 65 years of age with a Mini Mental Test score ≥ 24) voluntarily to participate in the study will be included.
Exclusion Criteria:
- Acute disease state (with ongoing urinary tract infection, active vaginitis, active Herpes infection)
- Stones in the bladder, ureter, or urethra in the last 3 months
- Having an ulcer appearance on cystoscopy
- For women: during pregnancy and/or breastfeeding
- Previous history of urological and/or pelvic malignancy
- Congenital anomaly of the upper and/or lower urinary tract
- who have started a new drug treatment in the last 3 months, or undergoing implantation operation of neuromodulation devices
- Diagnosed with opioid dependence
- Neurogenic bladder dysfunction or concomitant neurologic conditions
- Not cooperating with assessment and/or treatment, and illiterate individuals
Sites / Locations
- Hacettepe University, Faculty of Physical Therapy and RehabilitationRecruiting
- Hacettepe University, Faculty of Physical Therapy and RehabilitationRecruiting
- Hacettepe UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
biopsychosocial model-based treatment
Conventional physiotherapy
Arm Description
Biopsychosocial model-based management will be applied including pain neuroscience education, functional exercises, and relaxation training.
Conventional physiotherapy will be applied including standard exercises and electrical stimulation.
Outcomes
Primary Outcome Measures
severity of symptoms
The Interstitial Cystitis Symptom and Problem Index will be used to assess the severity of symptoms. This scale consists of two separate parts as symptom and problem index, both of which are four questions. Participants will be asked to fill in both parts.
Secondary Outcome Measures
severity of pain
Pain severity will be evaluated with the Visual Analogue Scale (VAS). Considering the last week, the patients will be asked to mark the severity of pain on a 10-centimeter (cm) straight line, with the starting end as "no pain" and the ending end as "unbearable pain". It will be calculated in cm by measuring the starting tip and the part marked by the patient.
Pain cognitions
Pain Catastrophizing Scale and Pain Self-Efficacy Questionnaire will be used to assess individuals' cognitions about pain (catastrophizing and self-efficacy).
urinary symptoms
A 3-day voiding diary will be used to evaluate Urinary Symptoms. On this chart, they are asked to record the time they urinate, the amount of urine, the presence of urinary incontinence, the amount and type of fluid consumed.
severity of disability
The Pain Disability Index will be used to question the impact of individuals' daily life due to their pain and the resulting disability.
psychological distress
The Hospital Anxiety and Depression Scale will be used to evaluate the psychological distress of individuals. The questionnaire has two sub-dimensions, depression and anxiety.
quality of life of the patients
Quality of Life will be assessed using the SF-36 scale. Short Form-36 will be used for evaluations. This questionnaire consists of eight different sub-parameters (physical function, physical role difficulty, general health status, pain status, energy/fatigue, social function, emotional role difficulty, and emotional well-being).
Full Information
NCT ID
NCT05155384
First Posted
December 10, 2021
Last Updated
December 13, 2021
Sponsor
Hacettepe University
1. Study Identification
Unique Protocol Identification Number
NCT05155384
Brief Title
Biopsychosocial and Conventional Approach in Bladder Pain Syndrome
Official Title
Comparison of Biopsychosocial and Conventional Approach in the Treatment of Bladder Pain Syndrome/Interstitial Cystitis
Study Type
Interventional
2. Study Status
Record Verification Date
December 2021
Overall Recruitment Status
Recruiting
Study Start Date
November 12, 2021 (Actual)
Primary Completion Date
October 15, 2022 (Anticipated)
Study Completion Date
October 15, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hacettepe University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The aim of the present study is to compare the effects of biopsychosocial and conventional approach on symptom severity, pain parameters (pain intensity and pain cognitions), disability, psychological distress and quality of life in patients who are suffering from bladder pain syndrome/interstitial cystitis. The study is designed as a randomized clinical trial including two parallel arms.
Individuals who meet the inclusion criteria and agree to participate will be randomly assigned into one of the two research arms: biopsychosocial approach group or conventional approach group. A biopsychosocial approach, which is a holistic approach that includes pain neuroscience education, relaxation training and cognitive exercises, will be applied to the patients in the first research arm for the treatment of chronic pain symptoms. For the patients in the second research arm, a conventional approach including pelvic floor stretching exercises and Transcutaneous Electrical Nerve Stimulation (TENS) will be applied for the treatment of chronic pain complaints. Treatments will be lasted for a total of six weeks, with two sessions per week. Participants will be evaluated at the baseline (before treatments) and at the end of the 6th week (after treatments). In the evaluations, information about the demographic and physical characteristics, medical and surgical background, medications and lifestyle characteristics (water, tea, coffee, alcohol, cigarette consumption, the presence constipation and physical activity level) of the individuals will be recorded. For primary or secondary outcome measures, Interstitial Cystitis Symptom and Problem Index, Visual Analog Scale, Pain Catastrophizing Scale, Pain Self-Efficacy Questionnaire, 3-day voiding diary, Pain Disability Index, Hospital Anxiety and Depression Scale, and Short Form-36 will be used. The present study is planned to be carried out with a total of 60 individuals, 30 for each study group based on a sample size analysis.
After reaching required sample for the present study, in patients with bladder pain syndrome/interstitial cystitis, the effects of biopsychosocial and conventional approach on symptom and problem severity, pain parameters, disability, psychological status and quality of life will be analyzed using (2*2) two-way ANOVA.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Interstitial Cystitis, Bladder Pain Syndrome
Keywords
chronic pain, pain neuroscience education, Bladder Pain Syndrome, Interstitial Cystitis
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
biopsychosocial model-based treatment
Arm Type
Experimental
Arm Description
Biopsychosocial model-based management will be applied including pain neuroscience education, functional exercises, and relaxation training.
Arm Title
Conventional physiotherapy
Arm Type
Active Comparator
Arm Description
Conventional physiotherapy will be applied including standard exercises and electrical stimulation.
Intervention Type
Other
Intervention Name(s)
Pain Neuroscience Education
Intervention Description
main topics of pain neuroscience education; neurophysiology of the nervous system, protective mechanism of pain, acute pain formation and chronic pain, factors that increase/reduce pain, central sensitization mechanism, neuroplasticity and treatment strategies in chronic pain.
Intervention Type
Other
Intervention Name(s)
Relaxation exercises
Intervention Description
Relaxation exercises are a training based on deep relaxation techniques and visual imagery. Relaxation exercises will be applied at the end of the training sessions.
Intervention Type
Other
Intervention Name(s)
Cognition target exercise
Intervention Description
Cognition target exercises are a time-based approach that is not symptom-conditioned (not based on fatigue or pain). It includes functional and dynamic exercises.
Intervention Type
Other
Intervention Name(s)
Pelvic floor stretching exercises
Intervention Description
Pelvic floor stretching exercises; consists of stretching exercises involving the pelvic floor muscles and surrounding group muscles (such as piriformis, hamstring, adductor group muscles and lumbar extensors).
Intervention Type
Device
Intervention Name(s)
Transcutaneous electrical nerve stimulation
Intervention Description
It will be used with superficial electrodes attached to the suprapubic region of the patients for 20 minutes in each session.
Primary Outcome Measure Information:
Title
severity of symptoms
Description
The Interstitial Cystitis Symptom and Problem Index will be used to assess the severity of symptoms. This scale consists of two separate parts as symptom and problem index, both of which are four questions. Participants will be asked to fill in both parts.
Time Frame
change in severity of symptoms from baseline up to end of 6th week
Secondary Outcome Measure Information:
Title
severity of pain
Description
Pain severity will be evaluated with the Visual Analogue Scale (VAS). Considering the last week, the patients will be asked to mark the severity of pain on a 10-centimeter (cm) straight line, with the starting end as "no pain" and the ending end as "unbearable pain". It will be calculated in cm by measuring the starting tip and the part marked by the patient.
Time Frame
change in severity of pain from baseline up to end of 6th week
Title
Pain cognitions
Description
Pain Catastrophizing Scale and Pain Self-Efficacy Questionnaire will be used to assess individuals' cognitions about pain (catastrophizing and self-efficacy).
Time Frame
change in pain cognitions from baseline up to end of 6th week
Title
urinary symptoms
Description
A 3-day voiding diary will be used to evaluate Urinary Symptoms. On this chart, they are asked to record the time they urinate, the amount of urine, the presence of urinary incontinence, the amount and type of fluid consumed.
Time Frame
change in urinary symptoms from baseline up to end of 6th week
Title
severity of disability
Description
The Pain Disability Index will be used to question the impact of individuals' daily life due to their pain and the resulting disability.
Time Frame
change in severity of disability from baseline up to end of 6th week
Title
psychological distress
Description
The Hospital Anxiety and Depression Scale will be used to evaluate the psychological distress of individuals. The questionnaire has two sub-dimensions, depression and anxiety.
Time Frame
change in psychological distress from baseline up to end of 6th week
Title
quality of life of the patients
Description
Quality of Life will be assessed using the SF-36 scale. Short Form-36 will be used for evaluations. This questionnaire consists of eight different sub-parameters (physical function, physical role difficulty, general health status, pain status, energy/fatigue, social function, emotional role difficulty, and emotional well-being).
Time Frame
change in quality of life from baseline up to end of 6th week
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Diagnosed with Bladder Pain Syndrome/Interstitial Cystitis
with chronic symptoms (more than 6 months)
Bladder pain severity in the last week should be at least 3/10 according to the Visual Analogue Scale (VAS)
Stable medication schedule
Individuals over the age of 18 (individuals over 65 years of age with a Mini Mental Test score ≥ 24) voluntarily to participate in the study will be included.
Exclusion Criteria:
Acute disease state (with ongoing urinary tract infection, active vaginitis, active Herpes infection)
Stones in the bladder, ureter, or urethra in the last 3 months
Having an ulcer appearance on cystoscopy
For women: during pregnancy and/or breastfeeding
Previous history of urological and/or pelvic malignancy
Congenital anomaly of the upper and/or lower urinary tract
who have started a new drug treatment in the last 3 months, or undergoing implantation operation of neuromodulation devices
Diagnosed with opioid dependence
Neurogenic bladder dysfunction or concomitant neurologic conditions
Not cooperating with assessment and/or treatment, and illiterate individuals
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ceren Gursen, PhD
Phone
+905380644120
Email
cerengursen@yahoo.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ceren Gürşen, PhD
Organizational Affiliation
Hacettepe University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hacettepe University, Faculty of Physical Therapy and Rehabilitation
City
Ankara
ZIP/Postal Code
06100
Country
Turkey
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ceren Gursen, Phd
Phone
+905380644120
Email
cerengursen@yahoo.com
First Name & Middle Initial & Last Name & Degree
Naside Mangir Bolat, PhD
First Name & Middle Initial & Last Name & Degree
Hilal Yazici
First Name & Middle Initial & Last Name & Degree
Turkan Albayrak, PhD
First Name & Middle Initial & Last Name & Degree
Serap Kaya
First Name & Middle Initial & Last Name & Degree
Gulbala Nakip
Facility Name
Hacettepe University, Faculty of Physical Therapy and Rehabilitation
City
Ankara
ZIP/Postal Code
06100
Country
Turkey
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ceren Gursen, PhD
Phone
+905380644120
Email
cerengursen@yahoo.com
Facility Name
Hacettepe University
City
Ankara
ZIP/Postal Code
06100
Country
Turkey
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ceren Gursen, PhD
Phone
+905380644120
Email
cerengursen@yahoo.com
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
9146003
Citation
O'Leary MP, Sant GR, Fowler FJ Jr, Whitmore KE, Spolarich-Kroll J. The interstitial cystitis symptom index and problem index. Urology. 1997 May;49(5A Suppl):58-63. doi: 10.1016/s0090-4295(99)80333-1.
Results Reference
background
PubMed Identifier
11124730
Citation
Von Korff M, Jensen MP, Karoly P. Assessing global pain severity by self-report in clinical and health services research. Spine (Phila Pa 1976). 2000 Dec 15;25(24):3140-51. doi: 10.1097/00007632-200012150-00009. No abstract available.
Results Reference
background
PubMed Identifier
25558568
Citation
Suren M, Okan I, Gokbakan AM, Kaya Z, Erkorkmaz U, Arici S, Karaman S, Kahveci M. Factors associated with the pain catastrophizing scale and validation in a sample of the Turkish population. Turk J Med Sci. 2014;44(1):104-8. doi: 10.3906/sag-1206-67.
Results Reference
background
PubMed Identifier
16446108
Citation
Nicholas MK. The pain self-efficacy questionnaire: Taking pain into account. Eur J Pain. 2007 Feb;11(2):153-63. doi: 10.1016/j.ejpain.2005.12.008. Epub 2006 Jan 30.
Results Reference
background
PubMed Identifier
6240632
Citation
Pollard CA. Preliminary validity study of the pain disability index. Percept Mot Skills. 1984 Dec;59(3):974. doi: 10.2466/pms.1984.59.3.974. No abstract available.
Results Reference
background
PubMed Identifier
6880820
Citation
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.
Results Reference
background
PubMed Identifier
11124729
Citation
Ware JE Jr. SF-36 health survey update. Spine (Phila Pa 1976). 2000 Dec 15;25(24):3130-9. doi: 10.1097/00007632-200012150-00008. No abstract available.
Results Reference
background
PubMed Identifier
23234638
Citation
Fitzgerald MP, Anderson RU, Potts J, Payne CK, Peters KM, Clemens JQ, Kotarinos R, Fraser L, Cosby A, Fortman C, Neville C, Badillo S, Odabachian L, Sanfield A, O'Dougherty B, Halle-Podell R, Cen L, Chuai S, Landis JR, Mickelberg K, Barrell T, Kusek JW, Nyberg LM; Urological Pelvic Pain Collaborative Research Network. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol. 2013 Jan;189(1 Suppl):S75-85. doi: 10.1016/j.juro.2012.11.018.
Results Reference
background
Learn more about this trial
Biopsychosocial and Conventional Approach in Bladder Pain Syndrome
We'll reach out to this number within 24 hrs